XIAP-mediated neuroprotection in retinal ischemia

Gene Therapy

Volumn 13, Issue 4, 2006, Pages 339-347

  Renwick, J ^a   Narang, M A ^a   Coupland, S G ^a   Xuan, J Y ^a   Baker, A N ^a   Brousseau, J ^a   Petrin, D ^a   Munger, R ^a   Leonard, B C ^a   Hauswirth, W W ^b   Korneluk, R G ^c   Tsilfidis, C ^a  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Adeno associated virus; GFP; Inner retina; Retinal ischemia; XIAP

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; X LINKED INHIBITOR OF APOPTOSIS;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; INTRAOCULAR HYPERTENSION; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; RETINA BIPOLAR GANGLION CELL; RETINA ISCHEMIA; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL COUNT; DEPENDOVIRUS; ELECTRORETINOGRAPHY; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IN SITU NICK-END LABELING; INJECTIONS; ISCHEMIA; MALE; NEURONS; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL DISEASES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ADENO-ASSOCIATED VIRUS; ANIMALIA; PARVOVIRUS;

EID: 32444434448     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302683     Document Type: Article

References (35)

1. Kohner EM. Diabetic retinopathy. Br Med Bull 1989; 45: 148-173.
2. Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001; 6: 69-81.
3. Rosenbaum DM, Rosenbaum PS, Gupta A, Michaelson MD, Hall DH, Kessler JA. Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res 1997; 37: 3445-3451.
4. Rosenbaum PS, Gupta H, Savitz SI, Rosenbaum DM. Apoptosis in the retina. Clin Neurosci 1997; 4: 224-232.
5. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997; 37: 3483-3493.
6. Luo X, Lambrou GN, Sahel JA, Hicks D. Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. Invest Ophthalmol Vis Sci 2001; 42: 2695-2705.
7. Adachi K, Kashii S, Masai H, Ueda M, Morizane C, Kaneda K et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol 1998; 236: 766-774.
8. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128: 733-738.
9. Seigel GM, Chiu L, Paxhia A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis 2000; 6: 157-163.
10. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22: RC216.
11. Lafuente MP, Villegas-Perez MP, Selles-Navarro I, Mayor-Torroglosa S, Miralles de Imperial J, Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience 2002; 109: 157-168.
12. Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45: 421-429.
13. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci 1999; 40: 2697-2705.
14. Singh M, Savitz SI, Hoque R, Gupta G, Roth S, Rosenbaum PS et al. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem 2001; 77: 466-475.
15. Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: There is more to life than Bcl2. Oncogene 2003; 22: 8568-8580.
16. Wang J, Lenardo MJ. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000; 113 (Part 5): 753-757.
17. MacFarlane M, Merrison W, Bratton SB, Cohen GM. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 2002; 277: 36611-36616.
18. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300-304.
19. Holcik M, Gibson H, Korneluk RG. XIAP: Apoptotic brake and promising therapeutic target. Apoptosis 2001; 6: 253-261.
20. McKinnon SJ, Lehman DM, Tahzib NG, Ransom NL, Reitsamer HA, Liston P et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002; 5: 780-787.
21. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2000; 20: 9126-9134.
22. Petrin D, Baker A, Coupland SG, Liston P, Narang M, Damji K et al. Structural and functional protection of photoreceptors from MNU-induced retinal degeneration by the X-linked inhibitor of apoptosis. Invest Ophthalmol Vis Sci 2003; 44: 2757-2763.
23. Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci 1999; 19: 5026-5033.
24. Petrin D, Baker A, Brousseau J, Coupland S, Liston P, Hauswirth WW et al. XIAP protects photoreceptors from n-methyln-nitrosourea-induced retinal degeneration. Adv Exp Med Biol 2003; 533: 385-393.
25. Unoki K, La Vail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994; 35: 907-915.
26. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 2000; 32: 249-256.
27. Gross RL, Hensley SH, Gao F, Wu SM. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: Potential neuroprotective effects of beta-blockers. Surv Ophthalmol 1999; 43 (Suppl 1): S162-S170.
28. Chun MH, Kim IB, Ju WK, Kim KY, Lee MY, Joo CK et al. Horizontal cells of the rat retina are resistant to degenerative processes induced by ischemia-reperfusion. Neurosci Lett 1999; 260: 125-128.
29. Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Muller cells. Invest Ophthalmol Vis Sci 2000; 41: 3183-3190.
30. Kolb H. Anatomical pathways for color vision in the human retina. Vis Neurosci 1991; 7: 61-74.
31. Jander S, Schroeter M, D'Urso D, Gillen C, Witte OW, Stoll G. Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia. Eur J Neurosci 1998; 10: 680-688.
32. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000; 98: 203-220.
33. Zhang C, Lam TT, Tso MO. Heterogeneous populations of microglia/ macrophages in the retina and their activation after retinal ischemia and reperfusion injury. Exp Eye Res 2005: 1-10.
34. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A 'humanized' green fluoresenct protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
35. Timmers AM, Zhang H, Squitieri A, Gonzalez-Pola C. Subretinal injections in rodent eyes: Effects on electrophysiology and histology of rat retina. Mol Vis 2001; 7: 131-137.